The SBIR/STTR Reauthorization Act of 2025 aims to extend and enhance the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. It permanently reauthorizes the core SBIR and STTR authorities, removing previous expiration dates. A key provision involves a gradual increase in the percentage of agency budgets allocated to these programs, reaching 7 percent for SBIR and 1 percent for STTR by fiscal year 2032 and beyond. To foster broader participation, the bill introduces new provisions for fellowships and internships for Phase II awardees, with a focus on outreach to women and socially/economically disadvantaged individuals. It also expands application assistance to historically underrepresented states, minority institutions, and Hispanic-serving institutions. These measures are designed to diversify the pool of small businesses engaging with federal research and development opportunities. The legislation significantly improves Technical and Business Assistance (TABA) by allowing award recipients to choose their vendors and increasing funding limits to $6,500 for Phase I and $50,000 for Phase II projects. It also mandates that agencies offer participation in I-Corps programs to awardees. Furthermore, the bill enhances transparency by requiring detailed reporting on subcontracted research institutions, including their type and specific designations, on the SBIR/STTR websites and databases. Commercialization efforts are bolstered through several initiatives. The bill mandates training for federal contracting officers on Phase III acquisitions, data rights, and sole-source awards to improve understanding and utilization. It also requires the Department of Defense to report denials of Phase III agreements. Each federal agency must designate a Technology Commercialization Official to guide awardees, coordinate with other agencies, and advocate for the transition of technologies to Phase III. The Act extends and expands several pilot programs, including the "Direct to Phase II" authority to all federal agencies, with specific funding limits, and the Civilian Agencies Commercialization Readiness program, all extended until at least 2030. It also extends the due diligence program for assessing security risks. Oversight is strengthened by requiring annual reports to Congress and public website publication, and a Comptroller General report on diversification and commercialization effectiveness. New safeguards are codified to prevent small businesses majority-owned by venture capital, hedge funds, or private equity firms from receiving awards if they are also majority-owned or controlled by a covered foreign entity . The bill also introduces an annual Commercialization Impact Assessment for high-volume Phase II awardees, measuring federal awards, commercial revenue, investments, mergers, spin-outs, and employment data to evaluate program effectiveness. Administrative and oversight assistance is extended and modified, allowing agencies to use a slightly higher percentage of funds (3.3%) for these purposes and requiring a portion of these funds to be transferred to the Small Business Administration for program administration. Finally, the bill includes Small Business Investment Companies (SBICs) in the provisions related to venture capital ownership, ensuring consistent application of rules.